Research ArticleArticle
Interleukin 28B Gene Polymorphisms in Hepatitis C Virus–related Cryoglobulinemic Vasculitis
Domenico Sansonno, Sabino Russi, Gaetano Serviddio, Vincenza Conteduca, Giovanna D’Andrea, Loredana Sansonno, Fabio Pavone, Gianfranco Lauletta, Maria Addolorata Mariggiò and Franco Dammacco
The Journal of Rheumatology December 2013, jrheum.130527; DOI: https://doi.org/10.3899/jrheum.130527
Domenico Sansonno
From the Section of Internal Medicine and Clinical Oncology, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari; Section of Internal Medicine, Department of Medical Sciences, and Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia, Italy. Supported by grants from the Italian Medicines Agency, funds for independent studies 2007, contract no. FARM7SJX (DS); Cassa di Risparmio di Puglia Foundation; Italian Association for Cancer Research, and the University of Bari. The funders had no role in the design, conduct, or analysis of the study. D. Sansonno, MD, PhD; S. Russi, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; G. Serviddio, MD, PhD; V. Conteduca, MD, Section of Internal Medicine, Department of Medical Sciences, University of Foggia; G. D’Andrea, PhD; L. Sansonno, MD, Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia; F. Pavone, MSc; G. Lauletta, MD, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; M.A. Mariggiò, MD, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; F. Dammacco, MD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School. Address correspondence to Dr. D. Sansonno, Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: domenicoettore.sansonno@uniba.it. Accepted for publication September 12, 2013.
Sabino Russi
From the Section of Internal Medicine and Clinical Oncology, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari; Section of Internal Medicine, Department of Medical Sciences, and Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia, Italy. Supported by grants from the Italian Medicines Agency, funds for independent studies 2007, contract no. FARM7SJX (DS); Cassa di Risparmio di Puglia Foundation; Italian Association for Cancer Research, and the University of Bari. The funders had no role in the design, conduct, or analysis of the study. D. Sansonno, MD, PhD; S. Russi, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; G. Serviddio, MD, PhD; V. Conteduca, MD, Section of Internal Medicine, Department of Medical Sciences, University of Foggia; G. D’Andrea, PhD; L. Sansonno, MD, Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia; F. Pavone, MSc; G. Lauletta, MD, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; M.A. Mariggiò, MD, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; F. Dammacco, MD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School. Address correspondence to Dr. D. Sansonno, Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: domenicoettore.sansonno@uniba.it. Accepted for publication September 12, 2013.
Gaetano Serviddio
From the Section of Internal Medicine and Clinical Oncology, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari; Section of Internal Medicine, Department of Medical Sciences, and Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia, Italy. Supported by grants from the Italian Medicines Agency, funds for independent studies 2007, contract no. FARM7SJX (DS); Cassa di Risparmio di Puglia Foundation; Italian Association for Cancer Research, and the University of Bari. The funders had no role in the design, conduct, or analysis of the study. D. Sansonno, MD, PhD; S. Russi, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; G. Serviddio, MD, PhD; V. Conteduca, MD, Section of Internal Medicine, Department of Medical Sciences, University of Foggia; G. D’Andrea, PhD; L. Sansonno, MD, Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia; F. Pavone, MSc; G. Lauletta, MD, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; M.A. Mariggiò, MD, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; F. Dammacco, MD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School. Address correspondence to Dr. D. Sansonno, Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: domenicoettore.sansonno@uniba.it. Accepted for publication September 12, 2013.
Vincenza Conteduca
From the Section of Internal Medicine and Clinical Oncology, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari; Section of Internal Medicine, Department of Medical Sciences, and Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia, Italy. Supported by grants from the Italian Medicines Agency, funds for independent studies 2007, contract no. FARM7SJX (DS); Cassa di Risparmio di Puglia Foundation; Italian Association for Cancer Research, and the University of Bari. The funders had no role in the design, conduct, or analysis of the study. D. Sansonno, MD, PhD; S. Russi, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; G. Serviddio, MD, PhD; V. Conteduca, MD, Section of Internal Medicine, Department of Medical Sciences, University of Foggia; G. D’Andrea, PhD; L. Sansonno, MD, Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia; F. Pavone, MSc; G. Lauletta, MD, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; M.A. Mariggiò, MD, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; F. Dammacco, MD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School. Address correspondence to Dr. D. Sansonno, Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: domenicoettore.sansonno@uniba.it. Accepted for publication September 12, 2013.
Giovanna D’Andrea
From the Section of Internal Medicine and Clinical Oncology, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari; Section of Internal Medicine, Department of Medical Sciences, and Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia, Italy. Supported by grants from the Italian Medicines Agency, funds for independent studies 2007, contract no. FARM7SJX (DS); Cassa di Risparmio di Puglia Foundation; Italian Association for Cancer Research, and the University of Bari. The funders had no role in the design, conduct, or analysis of the study. D. Sansonno, MD, PhD; S. Russi, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; G. Serviddio, MD, PhD; V. Conteduca, MD, Section of Internal Medicine, Department of Medical Sciences, University of Foggia; G. D’Andrea, PhD; L. Sansonno, MD, Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia; F. Pavone, MSc; G. Lauletta, MD, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; M.A. Mariggiò, MD, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; F. Dammacco, MD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School. Address correspondence to Dr. D. Sansonno, Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: domenicoettore.sansonno@uniba.it. Accepted for publication September 12, 2013.
Loredana Sansonno
From the Section of Internal Medicine and Clinical Oncology, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari; Section of Internal Medicine, Department of Medical Sciences, and Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia, Italy. Supported by grants from the Italian Medicines Agency, funds for independent studies 2007, contract no. FARM7SJX (DS); Cassa di Risparmio di Puglia Foundation; Italian Association for Cancer Research, and the University of Bari. The funders had no role in the design, conduct, or analysis of the study. D. Sansonno, MD, PhD; S. Russi, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; G. Serviddio, MD, PhD; V. Conteduca, MD, Section of Internal Medicine, Department of Medical Sciences, University of Foggia; G. D’Andrea, PhD; L. Sansonno, MD, Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia; F. Pavone, MSc; G. Lauletta, MD, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; M.A. Mariggiò, MD, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; F. Dammacco, MD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School. Address correspondence to Dr. D. Sansonno, Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: domenicoettore.sansonno@uniba.it. Accepted for publication September 12, 2013.
Fabio Pavone
From the Section of Internal Medicine and Clinical Oncology, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari; Section of Internal Medicine, Department of Medical Sciences, and Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia, Italy. Supported by grants from the Italian Medicines Agency, funds for independent studies 2007, contract no. FARM7SJX (DS); Cassa di Risparmio di Puglia Foundation; Italian Association for Cancer Research, and the University of Bari. The funders had no role in the design, conduct, or analysis of the study. D. Sansonno, MD, PhD; S. Russi, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; G. Serviddio, MD, PhD; V. Conteduca, MD, Section of Internal Medicine, Department of Medical Sciences, University of Foggia; G. D’Andrea, PhD; L. Sansonno, MD, Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia; F. Pavone, MSc; G. Lauletta, MD, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; M.A. Mariggiò, MD, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; F. Dammacco, MD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School. Address correspondence to Dr. D. Sansonno, Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: domenicoettore.sansonno@uniba.it. Accepted for publication September 12, 2013.
Gianfranco Lauletta
From the Section of Internal Medicine and Clinical Oncology, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari; Section of Internal Medicine, Department of Medical Sciences, and Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia, Italy. Supported by grants from the Italian Medicines Agency, funds for independent studies 2007, contract no. FARM7SJX (DS); Cassa di Risparmio di Puglia Foundation; Italian Association for Cancer Research, and the University of Bari. The funders had no role in the design, conduct, or analysis of the study. D. Sansonno, MD, PhD; S. Russi, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; G. Serviddio, MD, PhD; V. Conteduca, MD, Section of Internal Medicine, Department of Medical Sciences, University of Foggia; G. D’Andrea, PhD; L. Sansonno, MD, Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia; F. Pavone, MSc; G. Lauletta, MD, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; M.A. Mariggiò, MD, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; F. Dammacco, MD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School. Address correspondence to Dr. D. Sansonno, Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: domenicoettore.sansonno@uniba.it. Accepted for publication September 12, 2013.
Maria Addolorata Mariggiò
From the Section of Internal Medicine and Clinical Oncology, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari; Section of Internal Medicine, Department of Medical Sciences, and Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia, Italy. Supported by grants from the Italian Medicines Agency, funds for independent studies 2007, contract no. FARM7SJX (DS); Cassa di Risparmio di Puglia Foundation; Italian Association for Cancer Research, and the University of Bari. The funders had no role in the design, conduct, or analysis of the study. D. Sansonno, MD, PhD; S. Russi, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; G. Serviddio, MD, PhD; V. Conteduca, MD, Section of Internal Medicine, Department of Medical Sciences, University of Foggia; G. D’Andrea, PhD; L. Sansonno, MD, Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia; F. Pavone, MSc; G. Lauletta, MD, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; M.A. Mariggiò, MD, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; F. Dammacco, MD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School. Address correspondence to Dr. D. Sansonno, Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: domenicoettore.sansonno@uniba.it. Accepted for publication September 12, 2013.
Franco Dammacco
From the Section of Internal Medicine and Clinical Oncology, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari; Section of Internal Medicine, Department of Medical Sciences, and Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia, Italy. Supported by grants from the Italian Medicines Agency, funds for independent studies 2007, contract no. FARM7SJX (DS); Cassa di Risparmio di Puglia Foundation; Italian Association for Cancer Research, and the University of Bari. The funders had no role in the design, conduct, or analysis of the study. D. Sansonno, MD, PhD; S. Russi, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; G. Serviddio, MD, PhD; V. Conteduca, MD, Section of Internal Medicine, Department of Medical Sciences, University of Foggia; G. D’Andrea, PhD; L. Sansonno, MD, Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia; F. Pavone, MSc; G. Lauletta, MD, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; M.A. Mariggiò, MD, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; F. Dammacco, MD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School. Address correspondence to Dr. D. Sansonno, Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: domenicoettore.sansonno@uniba.it. Accepted for publication September 12, 2013.
Article Information
jrheum.130527
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online December 1, 2013.
Article Versions
- You are currently viewing a Latest version of this article (December 1, 2013 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2013 The Journal of Rheumatology
Author Information
- Domenico Sansonno,
- Sabino Russi,
- Gaetano Serviddio,
- Vincenza Conteduca,
- Giovanna D’Andrea,
- Loredana Sansonno,
- Fabio Pavone,
- Gianfranco Lauletta,
- Maria Addolorata Mariggiò and
- Franco Dammacco
- From the Section of Internal Medicine and Clinical Oncology, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari; Section of Internal Medicine, Department of Medical Sciences, and Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia, Foggia, Italy.
Supported by grants from the Italian Medicines Agency, funds for independent studies 2007, contract no. FARM7SJX (DS); Cassa di Risparmio di Puglia Foundation; Italian Association for Cancer Research, and the University of Bari. The funders had no role in the design, conduct, or analysis of the study.
D. Sansonno, MD, PhD; S. Russi, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; G. Serviddio, MD, PhD; V. Conteduca, MD, Section of Internal Medicine, Department of Medical Sciences, University of Foggia; G. D’Andrea, PhD; L. Sansonno, MD, Section of Medical Genetics, Department of Biomedical Sciences, University of Foggia; F. Pavone, MSc; G. Lauletta, MD, PhD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; M.A. Mariggiò, MD, Laboratory of General Pathology and Experimental Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School; F. Dammacco, MD, Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School.
Address correspondence to Dr. D. Sansonno, Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: domenicoettore.sansonno@uniba.it.
Accepted for publication September 12, 2013.
Article usage
Statistics from Altmetric.com
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Interleukin 28B Gene Polymorphisms in Hepatitis C Virus–related Cryoglobulinemic Vasculitis
Domenico Sansonno, Sabino Russi, Gaetano Serviddio, Vincenza Conteduca, Giovanna D’Andrea, Loredana Sansonno, Fabio Pavone, Gianfranco Lauletta, Maria Addolorata Mariggiò, Franco Dammacco
The Journal of Rheumatology Dec 2013, jrheum.130527; DOI: 10.3899/jrheum.130527
Interleukin 28B Gene Polymorphisms in Hepatitis C Virus–related Cryoglobulinemic Vasculitis
Domenico Sansonno, Sabino Russi, Gaetano Serviddio, Vincenza Conteduca, Giovanna D’Andrea, Loredana Sansonno, Fabio Pavone, Gianfranco Lauletta, Maria Addolorata Mariggiò, Franco Dammacco
The Journal of Rheumatology Dec 2013, jrheum.130527; DOI: 10.3899/jrheum.130527